Caption Management »

G1 Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 367k 4.32
2019-12-31 $4.7M 178k 26.43
2019-09-30 $3.4M 150k 22.78

More positions owned by Caption Management

Citigroup Com New Put Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Sarepta Therapeutics Call Option (SRPT)
Metropcs Communications Call Option (TMUS)
Mondelez Intl Cl A Put Option (MDLZ)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Cytokinetics Com New Call Option (CYTK)
AmerisourceBergen Call Option (COR)
Capri Holdings SHS Call Option (CPRI)
United States Steel Corporation Call Option (X)
Viking Therapeutics Call Option (VKTX)
Alnylam Pharmaceuticals Call Option (ALNY)
Adobe Systems Incorporated Put Option (ADBE)
ResMed Call Option (RMD)

View all positions for Caption Management

Top funds holding G1 Therapeutics

Vanguard Group
Susquehanna International
Renaissance Technologies
Raymond James & Associates
D. E. Shaw & Co
BlackRock
Geode Capital Management
Goldman Sachs Group
Millennium Management
Acadian Asset Management
Standard Life Aberdeen
Connor, Clark & Lunn Investment Management
HAP Trading
Bank of America Corporation
Jacobs Levy Equity Management

View all funds holding G1 Therapeutics